Lundbeck's head of R&D to join board of e-health firm Brain+
The publicly listed firm in Denmark has lured Johan Luthman to the board table, which following an expansion will seat five members instead of three.
by christian bundgaard, translated by daniel pedersen
Danish e-health firm Brain+ will strengthen its board markedly by electing three life science profiles, one of which is none other than Johan Luthman, Lundbeck’s head of research and development, to the company’s board of directors at an upcoming extraordinary general meeting on Sept. 2, according to a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lundbeck VP joins board of migraine firm
For subscribers
